Dr. S. Mohsen Asghari was born in 1978, in Tehran. He was graduated in Professor Hesabi high school in Tehran (1996), received his B.Sc. in Biology-Animal Sciences from Gorgan University of Agricultural Sciences, Gorgan (2000), and his M.Sc. (2003) and Ph.D. (2008) in Biochemistry from Tarbiat Modares University, Tehran, Iran. During M.Sc. and Ph.D., the focus of his studies was on the structure-function relationships of enzymes and rational protein engineering. After a sabbatical in Utrecht University, the Netherlands, he was joined the University of Guilan at 2009 as assistant professor. Dr Asghari was promoted to associate professor of biochemistry in 2017 and, since 2020, he has joined to IBB.
He is teaching enzymology, cell signaling and biochemistry of cancer for M.Sc. and Ph.D. students of IBB, enzymology for Ph.D. students of biotechnology (College of Science), and advanced biochemical engineering for Ph.D. students of biotechnology (School of Chemical Engineering).
Dr. Asghari's group aims to find and develop the novel vascular endothelial growth factor receptor (VEGFR)-targeting peptides to combat pathological angiogenesis in tumors and major blinding retinal diseases such as aged macular degeneration (AMD), and improve tumor imaging. Moreover, nanomedicinal systems are being used to combine cancer treatment and tumor imaging. His Lab., Biochemical Engineering Lab., has close collaborations with Tehran University of Medical Sciences Preclinical Core Facility, Tehran University of Medical Sciences Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences Ophthalmic Research Center and KNTU Peptide Synthesis Lab.
No items yet!
No items yet!